Browse the corpus

REFERENCES American Thoracic Society and Infectious Diseases Society of America, “Guidelines for the Management of Adults With Hospital-Acquired, Ventilator-Associated, and Healthcare-Associated Pneumonia,” Am J Respir Crit Care Med , 2005, 171(4):388-416. [PubMed 15699079 ] Armstrong DK, Hodgman T, Visconti JA , et al, “Hemodialysis of Amikacin in Critically Ill Patients,” Crit Care Med , 1988, 16(5):517-20. [PubMed 3359790 ] Bauer LA and Blouin RA, “Influence of Age on Amikacin Pharmacokinetics in Patients Without Renal Disease. Comparison With Gentamicin and Tobramycin,” Eur J Clin Pharmacol , 1983, 24(5):639-42. [PubMed 6873143 ] Begg EJ and Barclay ML, “Aminoglycosides - 50 Years On,” Br J Clin Pharmacol , 1995, 39(6):597-603. [PubMed 7654476 ] Chow MS, Quintiliani R, and Nightingale CH, " In Vivo Inactivation of Tobramycin by Ticarcillin. A Case Report," JAMA , 1982, 247(5):658-9. [PubMed 6798229 ] Cunha BA, “Aminoglycosides: Current Role in Antimicrobial Therapy,” Pharmacotherapy , 1988, 8(6):334-50. [PubMed 3146747 ] Daly JS, Dodge RA, Glew RH, et al, "Effect of Time and Temperature on Inactivation of Aminoglycosides by Ampicillin at Neonatal Dosages," J Perinatol , 1997, 17(1):42-5. [PubMed 9069064 ] Dowell JA, Korth-Bradley J, Milisci M, et al, "Evaluating Possible Pharmacokinetic Interactions Between Tobramycin, Piperacillin, and a Combination of Piperacillin and Tazobactam in Patients With Various Degrees of Renal Impairment," J Clin Pharmacol , 2001, 41:979-86. [PubMed 11549103 ] Edson RS and Terrell CL, “The Aminoglycosides,” Mayo Clin Proc , 1999, 74(5):519-28. [PubMed 10319086 ] Farchione LA, "Inactivation of Aminoglycosides by Penicillins," J Antimicrob Chemother , 1982, 8(Suppl A):27-36. Flandrois JP, Bouletreau P, Auboyer R, et al, “Accidental Amikacin Overdose in Man: Emergency Therapy by Extrarenal Dialysis,” Infection , 1979, 7:190-1. [PubMed 511337 ] Fuchs PC, Stickel S, Anderson PH, et al, " In Vitro Inactivation of Aminoglycosides by Sulbactam, Other Beta-Lactams, and Sulbactam-Beta-Lactam Combinations," Antimicrob Agents Chemother , 1991, 35(1):182-4. [PubMed 2014975 ] Gilbert DN, “Once-Daily Aminoglycoside Therapy,” Antimicrob Agents Chemother , 1991, 35(3):399-405. [PubMed 2039189 ]

Fuchs PC, Stickel S, Anderson PH, et al, " In Vitro Inactivation of Aminoglycosides by Sulbactam, Other Beta-Lactams, and Sulbactam-Beta-Lactam Combinations," Antimicrob Agents Chemother , 1991, 35(1):182-4. [PubMed 2014975 ] Gilbert DN, “Once-Daily Aminoglycoside Therapy,” Antimicrob Agents Chemother , 1991, 35(3):399-405. [PubMed 2039189 ] Gilbert VE, Beals JD, Natelson ST, et al, “Treatment of Cerebrospinal Fluid Leaks and Gram-negative Bacillary Meningitis With Large Doses of Intrathecal Amikacin and Systemic Antibiotics,” Neurosurgery , 1986, 18(4):402-06. [PubMed 3754626 ] Green FJ, Lavelle KJ, and Aronoff GR, “Management of Amikacin Overdose,” Am J Kidney Dis , 1981, 1:110-2. [PubMed 7332003 ] Griffith DE, Aksamit T, Brown-Elliott BA, et al, “An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases,” Am J Respir Crit Care Med , 2007, 175(4):367-416. [PubMed 17277290 ] Guardado AR, Blanco A, Asensi V, et al, “Multidrug-Resistant Acinetobacter Meningitis in Neurosurgical Patients With Intraventricular Catheters: Assessment of Different Treatments,” J Antimicrob Chemother , 2008, 61(4):908-13. [PubMed 18281693 ] Halstenson CE, Wong MO, Herman CS, et al, "Effect of Concomitant Administration of Piperacillin on the Dispositions on Isepamicin and Gentamicin in Patients With End-Stage Renal Disease," Antimicrob Agents Chemother , 1992, 36(9):1832-36. [PubMed 1416875 ] Heintz BH, Matzke GR, Dager WE, “Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis,” Pharmacotherapy , 2009, 29(5):562-77. [PubMed 19397464 ] Hitt CM, Patel KB, Nicolau DP, et al, "Influence of Piperacillin-Tazobactam on Pharmacokinetics of Gentamicin Given Once Daily," Am J Health Syst Pharm , 1997, 54(23):2704-8. [PubMed 9408514 ] Ho PW, Pien FD, and Kominami N, “Massive Amikacin Overdose,” Ann Intern Med , 1979, 91:227-8. [PubMed 464467 ] Iseman MD, “Treatment of Multidrug-Resistant Tuberculosis,” N Engl J Med , 1993, 329(11):784-91. [PubMed 8350889 ] Kasiakou SK, Rafailidis PI, Liaropoulos K, et al, “Cure of Post-Traumatic Recurrent Multiresistant Gram-Negative Rod Meningitis With Intraventricular Colistin,” J Infect , 2005, 50(4):348-52. [PubMed 15845435 ]

Iseman MD, “Treatment of Multidrug-Resistant Tuberculosis,” N Engl J Med , 1993, 329(11):784-91. [PubMed 8350889 ] Kasiakou SK, Rafailidis PI, Liaropoulos K, et al, “Cure of Post-Traumatic Recurrent Multiresistant Gram-Negative Rod Meningitis With Intraventricular Colistin,” J Infect , 2005, 50(4):348-52. [PubMed 15845435 ] Kenyon CF, Knoppert DC, Lee SK, et al, “Amikacin Pharmacokinetics and Suggested Dosage Modifications for the Preterm Infant,” Antimicrob Agents Chemother , 1990, 34(2):265-8. [PubMed 2327775 ] Konishi H, Goto M, Nakamoto Y, et al, "Tobramycin Inactivation by Carbenicillin, Ticarcillin, and Piperacillin," Antimicrob Agents Chemother , 1983, 23(5):653-57. [PubMed 6223576 ] Lau A, Lee M, Flascha S, et al, "Effect of Piperacillin on Tobramycin Pharmacokinetics in Patients With Normal Renal Function," Antimicrob Agents Chemother , 1983, 24(4):533-37. [PubMed 6651279 ] Lortholary O, Tod M, Cohen Y, et al, “Aminoglycosides,” Med Clin North Am , 1995, 79(4):761-87. [PubMed 7791422 ] McCormack JP and Jewesson PJ, “A Critical Re-evaluation of the “Therapeutic Range” of Aminoglycosides,” Clin Infect Dis , 1992, 14(1):320-39 Nicolau DP, Freeman CD, Belliveau PP, et al, “Experience With a Once-Daily Aminoglycoside Program Administered to 2184 Adult Patients,” Antimicrob Agents Chemother , 1995, 39(3):650-5. [PubMed 7793867 ] Preston SL and Briceland LL, “Single Daily Dosing of Aminoglycosides,” Pharmacotherapy , 1995, 15(3):297-316. [PubMed 7667165 ] Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex, “Recommendations on Prophylaxis and Therapy for Disseminated Mycobacterium avium Complex Disease in Patients Infected With the Human Immunodeficiency Virus,” N Engl J Med , 1993, 329(12):898-904. [PubMed 8395019 ] “Results of the Endophthalmitis Vitrectomy Study. A Randomized Trial of Immediate Vitrectomy and of Intravenous Antibiotics for the Treatment of Postoperative Bacterial Endophthalmitis. Endophthalmitis Vitrectomy Study Group,” Arch Ophthalmol , 1995, 113(12):1479-96. [PubMed 7487614 ] Roth DB and Flynn HW Jr, “Antibiotic Selection in the Treatment of Endophthalmitis: The Significance of Drug Combinations and Synergy,” Surv Ophthalmol , 1997, 41(5):395-401. [PubMed 9163836 ]

“Results of the Endophthalmitis Vitrectomy Study. A Randomized Trial of Immediate Vitrectomy and of Intravenous Antibiotics for the Treatment of Postoperative Bacterial Endophthalmitis. Endophthalmitis Vitrectomy Study Group,” Arch Ophthalmol , 1995, 113(12):1479-96. [PubMed 7487614 ] Roth DB and Flynn HW Jr, “Antibiotic Selection in the Treatment of Endophthalmitis: The Significance of Drug Combinations and Synergy,” Surv Ophthalmol , 1997, 41(5):395-401. [PubMed 9163836 ] Russoe ME and Atkins-Thor E, "Gentamicin and Ticarcillin in Subjects With End-Stage Renal Disease. Comparison of Two Assay Methods and Evaluation of Inactivation Rate," Clin Nephrol , 1981, 15(4):175-80. [PubMed 7237864 ] Starke JR and Correa AG, “Management of Mycobacterial Infection and Disease in Children,” Pediatr Infect Dis J , 1995, 14(6):455-69. [PubMed 7667049 ] Thompson MIB, Russo ME, Saxon BJ, et al, "Gentamicin Inactivation by Piperacillin or Carbenicillin in Patients With End-Stage Renal Disease," Antimicrob Agents Chemother , 1982, 21(2):268-73. [PubMed 6462107 ] Trotman RL, Williamson JC, Shoemaker DM, et al, "Antibiotic Dosing in Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy," Clin Infect Dis , 2005, 41(8):1159-66. [PubMed 16163635 ] Tunkel AR, Hartman BJ, Kaplan SL, et al, “Practice Guidelines for the Management of Bacterial Meningitis,” Clin Infect Dis , 2004, 39(9):1267-84. [PubMed 15494903 ] Van der Auwera P, “Pharmacokinetic Evaluation of Single Daily Dose Amikacin,” J Antimicrob Chemother , 1991, 27(Suppl C):63-71. Vanhaeverbeek M, Siska G, Douchamps J, et al, “Comparison of the Efficacy and Safety of Amikacin Once or Twice-a-Day in the Treatment of Severe Gram-Negative Infections in the Elderly,” Int J Clin Pharmacol Ther Toxicol , 1993, 31(3):153-6. [PubMed 8468114 ] Viollier AF, Standiford HC, Drusano GL, et al, "Comparative Pharmacokinetics and Serum Bactericidal Activity of Mezlocillin, Ticarcillin and Piperacillin, With and Without Gentamicin," J Antimicrob Chemother , 1985, 15(5):597-606. [PubMed 4008387 ] Vogelstein B, Kowarski A, and Lietman PS, “The Pharmacokinetics of Amikacin in Children,” J Pediatr , 1977, 91(2):333-9. [PubMed 874697 ] Vozeh S, Schmidlin O, and Taeschner W, “Pharmacokinetic Drug Data,” Clin Pharmacokinetics , 1988, 15(4):254-82. [PubMed 3191648 ]

Viollier AF, Standiford HC, Drusano GL, et al, "Comparative Pharmacokinetics and Serum Bactericidal Activity of Mezlocillin, Ticarcillin and Piperacillin, With and Without Gentamicin," J Antimicrob Chemother , 1985, 15(5):597-606. [PubMed 4008387 ] Vogelstein B, Kowarski A, and Lietman PS, “The Pharmacokinetics of Amikacin in Children,” J Pediatr , 1977, 91(2):333-9. [PubMed 874697 ] Vozeh S, Schmidlin O, and Taeschner W, “Pharmacokinetic Drug Data,” Clin Pharmacokinetics , 1988, 15(4):254-82. [PubMed 3191648 ] Walterspiel JN, Feldman S, Van R, et al, "Comparative Inactivation of Isepamicin, Amikacin, and Gentamicin by Nine Beta-Lactams and Two Beta-Lactamase Inhibitors, Cilastatin and Heparin," Antimicrob Agents Chemother , 1991, 35(9):1875-8. [PubMed 1952861 ] Wilson W, Taubert KA, Gewitz M, et al, “Prevention of Infective Endocarditis. Guidelines From the American Heart Association. A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group,” Circulation , 2007, 115. Available at file://circ.ahajournals.org/cgi/reprint/CIRCULATIONAHA.106.183095v1; last accessed July 26, 2007. [PubMed 17446442 ] Yasuhara H, Kobayashi S, Sakamoto K, et al, “Pharmacokinetics of Amikacin and Cephalothin in Bedridden Elderly Patients,” J Clin Pharmacol , 1982, 22(8-9):403-9. [PubMed 7130429 ] Topic 8536 Version 44.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [0604-202.43.93.2-49404BB9CF-S244013.14]